miércoles, 2 de diciembre de 2015

Trabectedin - National Cancer Institute

Trabectedin - National Cancer Institute

National Cancer Institute

National Cancer Institute


  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
This page contains brief information about trabectedin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA Approved

Use in Cancer

Trabectedin is approved to treat:
Trabectedin is also being studied in the treatment of other types of cancer.

More About Trabectedin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Trabectedin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

No hay comentarios:

Publicar un comentario